ZNF16 and cholangiocarcinoma: The GEPIA database (Accessed March 2, 2020) [14] showed a significant correlation between the expression of mRNA of FAM83H and ZNF16 in cholangiocarcinoma (Spearman’s correlation, R = 0.82, p <  0.001), hepatocellular carcinoma (Spearman’s correlation, R = 0.60, p <  0.001), and pancreatic adenocarcinoma (Spearman’s correlation, R = 0.40, p <  0.001).